$377 Million is the total value of Ghost Tree Capital, LLC's 49 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | New | INVESCO QQQ TRput | $33,168,000 | – | 174,200 | +100.0% | 8.80% | – |
| XLV | New | SELECT SECTOR SPDR TRcall | $21,676,000 | – | 244,700 | +100.0% | 5.75% | – |
| VSTM | New | VERASTEM INC | $3,960,000 | – | 1,500,000 | +100.0% | 1.05% | – |
| ZGNX | New | ZOGENIX INC | $3,710,000 | – | 150,000 | +100.0% | 0.98% | – |
| XENE | New | XENON PHARMACEUTICALS INC | $3,686,000 | – | 325,000 | +100.0% | 0.98% | – |
| New | TRILLIUM THERAPEUTICS INC | $3,333,000 | – | 825,000 | +100.0% | 0.88% | – | |
| FIXX | New | HOMOLOGY MEDICINES INC | $3,108,000 | – | 200,000 | +100.0% | 0.82% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $2,779,000 | – | 350,000 | +100.0% | 0.74% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $2,743,000 | – | 250,000 | +100.0% | 0.73% | – |
| STSA | New | SATSUMA PHARMACEUTICALS INC | $2,475,000 | – | 115,000 | +100.0% | 0.66% | – |
| FXE | New | INVESCO CURRENCYSHARES EURO | $2,173,000 | – | 20,830 | +100.0% | 0.58% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $1,867,000 | – | 65,000 | +100.0% | 0.50% | – |
| CUE | New | CUE BIOPHARMA INC | $1,774,000 | – | 125,000 | +100.0% | 0.47% | – |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $1,223,000 | – | 372,806 | +100.0% | 0.32% | – |
| BIIB | New | BIOGEN INC | $1,028,000 | – | 3,250 | +100.0% | 0.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.